Twelve-Month Regimen Of Oral Itraconazole Superior To Six-Month Regimen In Reducing Relapses Of Chronic Pulmonary Aspergillosis, Trial Demonstrates

Healio (5/4, Stulpin) reports “a single-center, open-label, randomized controlled trial” has “demonstrated that 12 months of oral itraconazole was superior to a 6-month regimen in reducing relapses of chronic pulmonary aspergillosis, researchers reported....